Based on genetic susceptibility (such as loss of filaggrin gene), the AD patients were found to have a defective skin barrier and dysregulation of the innate immune system, which results in failure of immunologic responses to allergens and microbial pathogens [23,24]. The gene discussed is FLG; the disease is Alzheimer disease.